Sentieon Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 15

Sentieon General Information

Description

Developer of bioinformatics software tools designed to process genomics data with high accuracy and high computing efficiency. The company's products are used for germline variant detection, tumor-normal somatic mutation detection, and comprehensive tumor characterization, enabling scientists, clinicians, and patients to benefit from precision data and computing efficiency, fast turnaround time, accuracy, and consistency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 160 East Tasman Drive
  • Suite 208
  • San Jose, CA 95134
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sentieon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 30-Sep-2015 $20M 000.00 00000 Completed Generating Revenue
1. Angel (individual) 12-Sep-2014 00.00 00.00 000.00 Completed Startup
To view Sentieon’s complete valuation and funding history, request access »

Sentieon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view Sentieon’s complete cap table history, request access »

Sentieon Patents

Sentieon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10424395-B2 Computation pipeline of single-pass multiple variant calls Active 27-Mar-2015 000000000
US-20160283654-A1 Computation pipeline of single-pass multiple variant calls Granted 27-Mar-2015 000000000 0
US-20160283655-A1 Computation pipeline of location-dependent variant calls Granted 27-Mar-2015 000000000 0
US-10424396-B2 Computation pipeline of location-dependent variant calls Active 27-Mar-2015 G16B30/00

Sentieon Executive Team (2)

Name Title Board Seat Contact Info
Jun Ye Ph.D Co-Founder, Chief Executive Officer, President & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Sentieon Board Members (1)

Name Representing Role Since
Jun Ye Ph.D Sentieon Co-Founder, Chief Executive Officer, President & Board Member 000 0000
To view Sentieon’s complete board members history, request access »

Sentieon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sentieon Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3E Bioventures Capital Venture Capital Minority 000 0000 000000 0
Amino Capital Venture Capital Minority 000 0000 000000 0
CLI Ventures Venture Capital Minority 000 0000 000000 0
Cybernaut Zfounder Ventures Venture Capital Minority 000 0000 000000 0
Eastlink Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »